SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654954-22-004476
Filing Date
2022-04-01
Accepted
2022-04-01 16:59:09
Documents
5
Period of Report
2022-05-18

Document Format Files

Seq Description Document Type Size
1 SCHEDULE-14A edsa_def14a.htm DEF 14A 429169
2 edsa_def14aimg1.jpg GRAPHIC 167178
3 edsa_def14aimg2.jpg GRAPHIC 160006
4 edsa_def14aimg3.jpg GRAPHIC 163392
5 edsa_def14aimg4.jpg GRAPHIC 133138
  Complete submission text file 0001654954-22-004476.txt   1289590
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37619 | Film No.: 22799152
SIC: 2834 Pharmaceutical Preparations